Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FM0QZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,722
Award facts
- Contract value 100% obligated
- $36,721.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,721.80 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements through open competition, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for TDAP vaccine syringes reflects the company's ongoing role in supporting the Defense Health Agency and broader Department of Defense healthcare operations through its comprehensive pharmaceutical prime vendor arrangement with the DLA.
Quick answers
Who was awarded contract SPE2DB25FM0QZ?
SPE2DB25FM0QZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FM0QZ worth?
The government has obligated $36,722 on SPE2DB25FM0QZ.
Is contract SPE2DB25FM0QZ an order under another contract?
Yes. SPE2DB25FM0QZ is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB25FM0QZ competed?
The extent of competition for SPE2DB25FM0QZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award